QQ客服 官方微博 反馈留言

	Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study
	Shen, Tian; Wang, Jiwei; Yu, Yingjun; Yu, Jinming
刊名	CLINICAL AND EXPERIMENTAL HYPERTENSION
	2019
卷号	41期号:3
关键词	Real-world study valsartan non-RAS CCB
ISSN号	1064-1963
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3607442
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Shen, Tian,Wang, Jiwei,Yu, Yingjun,et al. Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study[J]. CLINICAL AND EXPERIMENTAL HYPERTENSION,2019,41(3).
APA	Shen, Tian,Wang, Jiwei,Yu, Yingjun,&Yu, Jinming.(2019).Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study.CLINICAL AND EXPERIMENTAL HYPERTENSION,41(3).
MLA	Shen, Tian,et al."Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study".CLINICAL AND EXPERIMENTAL HYPERTENSION 41.3(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。